Alvotech (ALVO) Capital Expenditures (2022 - 2026)

Alvotech (ALVO) posted Capital Expenditures of -$7.1 million for Q1 2026, down 105.94% on a QoQ basis from $120.2 million in Q4 2025, and up 69.2% year-over-year from -$4.2 million in Q1 2025.

Alvotech (ALVO) Capital Expenditures (2022 - 2026) Analysis & Trends

Alvotech's Capital Expenditures history runs 5 years deep, the most recent figure standing at -$7.1 million for Q1 2026.

  • Quarterly Capital Expenditures rose 69.2% year-over-year to -$7.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $80.5 million (up 183.12% YoY) and the FY2025 annual result came in at $64.5 million, up 20.14% from the prior year.
  • Capital Expenditures was -$7.1 million for Q1 2026 at Alvotech, down from $120.2 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $120.2 million in Q4 2025 and bottomed at -$53.7 million in Q4 2024.
  • A 5-year average of -$8.8 million and a median of -$13.6 million in 2025 frame the typical range for Capital Expenditures.
  • Peak annual rise in Capital Expenditures reached 324.0% in 2025, while the deepest fall reached 469.85% in 2025.
  • Alvotech's Capital Expenditures stood at -$37.9 million in 2022, then climbed by 12.27% to -$33.2 million in 2023, then tumbled by 61.46% to -$53.7 million in 2024, then soared by 324.0% to $120.2 million in 2025, then sank by 105.94% to -$7.1 million in 2026.
  • Business Quant data shows ALVO's Capital Expenditures at -$7.1 million in Q1 2026, $120.2 million in Q4 2025, and -$18.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Haleon 89.51 Bn 87.64 Bn - -
2 Teva Pharmaceutical Industries 36.00 Bn 32.26 Bn 1.97 Bn 168.00 Mn
3 Zoetis 32.61 Bn 30.67 Bn 1.62 Bn 110.00 Mn
4 Takeda Pharmaceutical 27.49 Bn 23.43 Bn 4.39 Bn 1.95 Bn
5 United Therapeutics 23.05 Bn 20.90 Bn 648.10 Mn 99.60 Mn
6 RedHill Biopharma 21.48 Bn 21.48 Bn - -
7 Viatris 20.26 Bn 18.46 Bn 1.16 Bn 39.90 Mn
8 Neurocrine Biosciences 17.79 Bn 16.47 Bn 800.70 Mn 1.40 Mn
9 Elanco Animal Health 12.64 Bn 12.21 Bn 785.00 Mn 51.00 Mn
10 Alvotech 924.10 Mn 924.10 Mn 5.09 Mn -7.14 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -7.14 Mn
Mar 31, 2026 -7.14 Mn
Dec 31, 2025 120.20 Mn
Dec 31, 2025 120.20 Mn
Sep 30, 2025 -18.93 Mn
Sep 30, 2025 -18.93 Mn
Jun 30, 2025 -13.62 Mn
Jun 30, 2025 -13.62 Mn
Mar 31, 2025 -23.19 Mn
Mar 31, 2025 -23.19 Mn
Dec 31, 2024 -53.66 Mn
Dec 31, 2024 -53.66 Mn
Sep 30, 2024 -13.82 Mn
Sep 30, 2024 -13.82 Mn
Jun 30, 2024 -6.20 Mn
Jun 30, 2024 -6.20 Mn
Mar 31, 2024 -4.07 Mn
Mar 31, 2024 -4.07 Mn
Dec 31, 2023 -33.23 Mn
Dec 31, 2023 -33.23 Mn